HHE Perspectives on Hospital and Industry Partnerships | Page 5

Executive summary
●
●
Currently there are structures in place within hospitals
which allow for hospital-wide strategies to be
developed to improve outcomes within their budgets.
However, there are many different types of structures
which involve a wide variety of stakeholders. There is
no ‘one size fits all’.
●

Many hospital stakeholders and healthcare system
decision makers, although wary of public–private
partnerships, believe that value-based offerings are
a move in the right direction. They believe that the
public sector must be prepared to engage with the
private sector and embrace new forms of thinking,
instead of a ‘we’ve always done it this way’ mentality.
●
●
●
Hospitals understand that partnerships have to be ‘win-
win’ so they need manufacturers to set out clearly what
both sides will gain. In order for hospitals to co-create
solutions with manufacturers, the manufacturers
would also need to be able to both demonstrate and be
involved in measuring their effects and outcomes.

Learnings from previous partnerships highlight
that the tender service process needs to be carefully
considered and discussed with potential suppliers to
ensure that they can help achieve the desired outcomes.
This process can take years.

Relationships between industry and hospital
stakeholders appear to be accepted and encouraged to
varying degrees in Europe. However, in Turkey, there
is a deliberate effort to reduce these interactions. This
was perceived to reduce the likelihood of the uptake of
value-based offerings in Turkey.
●
●
There is a growing acceptance that all the skills needed
to develop outcome-based solutions are not necessarily
‘in-house’, and that they may need to be brought in via
hospital-industry partnerships. The UK respondents
cited the potential benefit of value-based hospital-
industry partnerships as a way to address some of the
current, severe shortages within the hospital sector.
Where pathway change is needed, partnerships with
industry could also potentially accelerate the process.
In the UK, it was suggested that engagements at
a Sustainability and Transformation Partnership
(STP) level with medical device companies could
potentially accelerate processes where changes to
pathways are needed.

Views varied on the specific areas with which
hospitals need the most support in order to improve
outcomes, increase patient satisfaction and reduce
costs. These ranged from specific areas, such as
oncology or theatre management, to technology for
medication compliance.
3
HHE 2018 | hospitalhealthcare.com